Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the USA / NCT04364503
Enrolling by invitation Observational

Compliant Analysis of Patient Samples and Data

NCT04364503 · tracked via the Priya Life Science USA tracker
Sponsor
Sequenom, Inc
Phase
Observational
Started
2018-03-17
Last updated
2026-07-21

Condition(s) studied

Pregnancy RelatedCancerInfectious Disease

Investigational drug(s) / intervention(s)

Multiple interventions depending on diagnostic test being run.

Multiple interventions depending on diagnostic test being run.: Remnant samples and corresponding data from multiple diagnostic tests will be stored for future research and development.

Study summary

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Arm 1 * All samples and data are de-identified and HIPAA compliant * Arm 2 * Subject is of scientific interest to the Sponsor or treating physician * Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected. Exclusion Criteria: * Arm 1 * Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development * Arm 2 * Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent

Primary outcome measure(s)

  • Remnant samples and data for research and development — Retrospective and Prospective collection. Samples and data may be collected for up 12 months after enrollment.
    Remnant samples and data for research and development
  • Sample and data collection from subjects of scientific interest — Prospective collection. Samples and data may be collected for up to 12 months after enrollment
    Collect additional clinical data and samples if needed from subjects tested by LabCorp or an affiliate.

Trial sites (9)

FacilityCityRegionStatus
Labcorp Los Angeles California
Sequenom, Inc San Diego California
Labcorp - Monogram Biosciences South San Francisco California
Labcorp - Esoterix Englewood Colorado
Labcorp - Litholink Itasca Illinois
Labcorp - Omniseq Buffalo New York
Labcorp Burlington North Carolina
Labcorp - Cytogenetics Research Triangle Park North Carolina
Labcorp Research Triangle Park North Carolina

More Sequenom, Inc. trials in the USA

Specimen Collection From Patients With Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay Recruiting
Non-Invasive Preeclampsia Screening and Biobank Recruiting
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy Recruiting
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix Recruiting

Other trials for the same condition

An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare. Recruiting
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors Recruiting
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study Enrolling by invitation
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors Recruiting
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04364503 on ClinicalTrials.gov ↗ ← All trials in the USA